HIGHLIGHTS
- What: The aim of the prospective monocentric study was to investigate the role of selenoprotein 1 (SEEP 1) as a potential biomarker for assessing the risk of myocardial injury after cardiac surgery. Making thorough risk assessments of patients with myocardial injury as soon as possible and preventing any unfavorable outcomes are the primary goals of the hunt for novel markers. Forty-five consecutive patients undergoing elective major heart surgery with CPB made up the final research population (the main reason for withdrawing the patient was the presence of impaired renal function and/or non-elective surgery) .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.